The Broker Innovation Lab celebrates brokers and other benefits stakeholders who have embraced the changing marketplace to position themselves and their business for future success
Alan Goforth is a freelance writer in suburban Kansas City. In addition to freelancing for several publications, he has written a dozen books about sports and other topics.
This week, the Biden administration unveiled the Global Health Security Strategy, which will work with 50 partner nations that include developing countries, such as Haiti and Bangladesh, to prevent future global pandemics.
A settlement between the drugmaker and insulin patients that would have capped patients' out-of-pocket insulin costs at $35 for 4 years has fallen apart, after an "unfavorable ruling" from the judge overseeing the case.
On Monday, the RansomHub cybercriminal hacking group followed through on threats to share sensitive medical and financial records stolen from Change Healthcare, despite the health tech firm allegedly paying a $22 million ransom.
The new bill is the latest attempt to restrict the use of environmental, social and governance factors in retirement plans by specifying that fiduciaries may consider only "risk and return" factors when making investment decisions.
The Centers for Medicare & Medicaid Services' final rule aims to stop brokers from steering beneficiaries to certain plans in exchange for higher reimbursement from insurers, while giving them more predictable compensation.
This new debt forgiveness - for those enrolled in the federal Saving on a Valuable Education (SAVE) Plan - comes days after the president unveiled a sweeping student loan forgiveness proposal providing relief for 30 million Americans.
Novo Nordisk's list price for a monthly package of Ozempic is $935.77 before insurance and other rebates, yet it can be manufactured for between $0.89 to $4.73 a month, according to researchers at Yale University.